MXPA05008190A - Derivado de oligosacarido. - Google Patents

Derivado de oligosacarido.

Info

Publication number
MXPA05008190A
MXPA05008190A MXPA05008190A MXPA05008190A MXPA05008190A MX PA05008190 A MXPA05008190 A MX PA05008190A MX PA05008190 A MXPA05008190 A MX PA05008190A MX PA05008190 A MXPA05008190 A MX PA05008190A MX PA05008190 A MXPA05008190 A MX PA05008190A
Authority
MX
Mexico
Prior art keywords
compound
oligosaccharide derivative
hydroxymethyl
diabetes
safe
Prior art date
Application number
MXPA05008190A
Other languages
English (en)
Inventor
Xiaoliu Li
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of MXPA05008190A publication Critical patent/MXPA05008190A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)

Abstract

Compuestos que tienen la formula (I) (ver formula (I)): (en donde A representa un grupo tal como un grupo ciclico, R1 y R2 representan grupos tales como grupos alquilo o grupos hidroximetilo, y n representa 1 o 2), o sales farmacologicamente aceptables del mismo o esteres farmacologicamente aceptables del mismo que tienen una actividad y estabilidad superiores, y son utiles para el tratamiento y/o prevencion de la diabetes mellitus o enfermedades similares.
MXPA05008190A 2003-01-30 2004-01-29 Derivado de oligosacarido. MXPA05008190A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003022800 2003-01-30
PCT/JP2004/000879 WO2004067542A1 (ja) 2003-01-30 2004-01-29 オリゴ糖誘導体

Publications (1)

Publication Number Publication Date
MXPA05008190A true MXPA05008190A (es) 2006-02-17

Family

ID=32820702

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008190A MXPA05008190A (es) 2003-01-30 2004-01-29 Derivado de oligosacarido.

Country Status (22)

Country Link
US (2) US7361744B2 (es)
EP (1) EP1589023B1 (es)
KR (1) KR101050981B1 (es)
CN (2) CN100360548C (es)
AT (1) ATE478884T1 (es)
AU (1) AU2004207726B2 (es)
BR (1) BRPI0406990A (es)
CA (1) CA2514931A1 (es)
DE (1) DE602004028799D1 (es)
DK (1) DK1589023T3 (es)
ES (1) ES2349736T3 (es)
HK (1) HK1077070A1 (es)
IL (1) IL169577A (es)
MX (1) MXPA05008190A (es)
NO (1) NO20053997L (es)
NZ (1) NZ541455A (es)
PL (1) PL377462A1 (es)
PT (1) PT1589023E (es)
RU (1) RU2290408C2 (es)
TW (1) TWI318202B (es)
WO (1) WO2004067542A1 (es)
ZA (1) ZA200506075B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200608967A (en) * 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
TW200612968A (en) * 2004-07-29 2006-05-01 Sankyo Co Oligosaccharide derivatives containing with heterocycle
TW200735880A (en) * 2006-01-27 2007-10-01 Sankyo Co Medicinal compositions for preventing or treating heart failure
GB0614947D0 (en) * 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2056801T3 (es) * 1986-08-13 1994-10-16 Hoechst Ag Oxirano-seudooligosacaridos, procedimiento para su preparacion, su utilizacion y preparados farmaceuticos.
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
JP4643775B2 (ja) * 1999-01-13 2011-03-02 日本食品化工株式会社 香気成分生成阻害剤
JP3909735B2 (ja) 1999-02-22 2007-04-25 キッコーマン株式会社 マルトオリゴ糖誘導体及びその用途
WO2000050494A1 (en) 1999-02-23 2000-08-31 Ips Corporation Low voc (volatile organic compounds), dimethyl-2-piperidone solvent-based, pvc and cpvc pipe and component adhesives and primers containing minimal or no tetrahydrofuran
WO2001094367A1 (fr) * 2000-06-06 2001-12-13 Kikkoman Corporation Derives de malto-oligosaccharide et utilisation correspondante

Also Published As

Publication number Publication date
AU2004207726A1 (en) 2004-08-12
NO20053997L (no) 2005-10-28
ATE478884T1 (de) 2010-09-15
HK1077070A1 (en) 2006-02-03
TWI318202B (en) 2009-12-11
CN101367851A (zh) 2009-02-18
US7632930B2 (en) 2009-12-15
IL169577A (en) 2010-06-16
KR101050981B1 (ko) 2011-07-21
EP1589023A1 (en) 2005-10-26
RU2005124286A (ru) 2006-01-27
ES2349736T3 (es) 2011-01-11
EP1589023A4 (en) 2008-12-10
CA2514931A1 (en) 2004-08-12
CN100360548C (zh) 2008-01-09
BRPI0406990A (pt) 2006-01-10
EP1589023B1 (en) 2010-08-25
NZ541455A (en) 2007-08-31
IL169577A0 (en) 2007-07-04
RU2290408C2 (ru) 2006-12-27
DK1589023T3 (da) 2010-12-13
PT1589023E (pt) 2010-10-29
AU2004207726B2 (en) 2007-03-15
US20060025350A1 (en) 2006-02-02
DE602004028799D1 (en) 2010-10-07
NO20053997D0 (no) 2005-08-29
TW200502204A (en) 2005-01-16
US20080194495A1 (en) 2008-08-14
CN1768073A (zh) 2006-05-03
KR20050094465A (ko) 2005-09-27
ZA200506075B (en) 2006-05-31
WO2004067542A1 (ja) 2004-08-12
PL377462A1 (pl) 2006-02-06
US7361744B2 (en) 2008-04-22

Similar Documents

Publication Publication Date Title
EP1679309A4 (en) ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
NO20045072L (no) Tablett med hoyt medikamentinnhold
EP1400529A4 (en) GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF
MY140638A (en) New heterocyclic compounds, which are active as inhibitors of beta-lactamases
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
CA2336412A1 (en) Medicament for treatment of diabetes
EP1634874A4 (en) imidazolidine
TW200745033A (en) Oxindole derivative as feeding control agent
EP1491190A4 (en) DECOMPOSITION INHIBITOR FOR CARTRIDGE EXTRACELLULAR MATRIX
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
DE60123827D1 (en) 1-methylcarbapenemderivate
MXPA05008190A (es) Derivado de oligosacarido.
NO20062307L (no) Spirofuropyridinarylderivater
MXPA05011521A (es) Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
CA2382654A1 (en) Novel a-500359 derivatives
BRPI0511824A (pt) radiossensibilizador
EA200500716A1 (ru) Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат
EP1707560A4 (en) HYDROXAMIC ACID DERIVATIVE AND THE DERIVATIVE INHIBITOR OF THE GENERATION OF AGE
EP1151993A4 (en) CYCLIC AMINE DERIVATIVES AND THEIR APPLICATIONS
MX2008002753A (es) Derivados de piridazinona utilizados para el tratamiento de dolor.
WO2008102716A1 (ja) Ａｄｈｄ関連疾患治療剤
TW200509927A (en) Chronic obstructive pulmonary disease therapeutic agent and method of treating chronic obstructive pulmonary disease using the same

Legal Events

Date Code Title Description
FG Grant or registration